期刊文献+

血清HIF-1α、组织P53表达水平对乳腺癌预后意义 被引量:2

Significance of the levels of serum HIF-1α and tissue P53 to prognosis of breast cancer
下载PDF
导出
摘要 目的探讨血清缺氧诱导因子-1(HIF-1)和组织P53的表达水平与乳腺癌预后的关系。方法悬浮芯片法检测117例乳腺原发浸润性导管癌、10例复发乳腺浸润性导管癌、20例乳腺良性肿瘤和31例正常人血清中HIF-1含量,并利用免疫组织化学检测其组织中P53蛋白的表达。结果原发、复发乳腺癌血清HIF-1和P53蛋白表达水平明显高于良性肿瘤和正常对照组(p<0.01),复发癌高于原发癌(p<0.05);血清HIF-1和组织P53蛋白水平在不同的病理学特征中差异有显著性(p<0.05);乳腺癌患者的HIF-1与P53表达水平呈正相关(r=0.544,=0.000)。结论血清HIF-1参与了乳腺浸润性导管癌的病理过程,是评估乳腺浸润性导管癌患者预后的重要指标。 Objective To investigate the relationship between the expression ofserum hypoxia-inducible factor 1(HIF-1α )and tissue P53 and prognosis of breast invasive ductal carcinoma.Methods Contents of serum HIF-1α in tissue and serum samples of 117 primary breast invasive ductal carcinoma,10 recurrent breast invasive ductal carcinoma,20 benign breast carcinoma and 31 healthy volunteers were detected by suspension array,and examining the expressions of P53 in them were examined by immunohistochemical method.Results The HIF-1α level and the expression of P53 in breast cancer were significantly higher than those in benign breast cancer and control group(p〈0.01);HIF-1α expression in recurrent breast cancer was significantly higher than that in primary ones in both tissue and serum samples(p〈0.05);there were significant differences of the levels of Serum HIF-1α and Tissue P53 in different pathological features(p〈0.05).Expressions of P53 were positively correlated with the content of HIF-1α(r=0.544,p=0.000) in the patients with breast cancer.Conclusion The serum HIF-1α may play an important role in the development and progression of breast invasive ductal cancer.These two markers combined can be used as an important prognosis indicator in breast invasive ductal carcinoma.
出处 《现代实用医学》 2010年第3期264-267,共4页 Modern Practical Medicine
基金 兰州军区医药卫生科研计划项目 编号:LXH-20-09 南方医科大学博士科研基金
关键词 乳腺肿瘤 乳腺浸润性导管癌 缺氧诱导因子-1 P53基因 免疫组织化学 Breast neoplasm Breast invasive duct carcinoma Hypoxia-inducible factor 1α P53 gene Immunohistochemistry
  • 相关文献

参考文献7

  • 1Zhong H,De Matzo AM,Laughner E,et al.Overexpression of h-ypoxia-inducible factor 1 incommon human caneers and theirmeta stases[J].Cancer Res,1999,59(22):5830-585,.
  • 2Zhang Q,Tang Q,Lu Q,et al,Green tea extract and(-)-epiga-llocatechin-3-gallatc inhibit hypoxia-and serum-induced HIF-1α-lpha protein accumulation and VEGF expression in human cervical carcinoma and hepatorna cells[J].Mol Cancer Ther,2006,5(5):1227-1238.
  • 3Chen HH,Su WC,Lin PW,et al,Hypoxia-indueible factor-Ialpha correlates with MET and metastasis in node-negative breast can cer[J].Breast Cancer Res Treat,2007,103(2):167-175.
  • 4马超,周庚寅,肖颖,高鹏,郭玲玲,林晓燕.HIF-1α P-gp在腋淋巴结阴性乳腺癌组织中的表达及意义[J].中国肿瘤临床,2007,34(1):10-13. 被引量:5
  • 5Yamamoto Y,Ibsuki M,Okumura Y,et al.Hypoxia-inducible factor lalpha is closely linked to an aggressive phenotype in breast cancer[J].Breast Cancer Res Treat,2008,110(3):465-475.
  • 6Suzuki H,Tomida A,Tsuruo T,et al.Dephosphorylated hypoxia-indueible factor 1α as a mediator of P53-dependent apoptosis dur-ing hypoxia[J].Oncogene,2001,20(41):5779-588.
  • 7Ravi R,Mookerjee B,Bhujwalla ZM,et al.Regulation of tumor an giogonesis by P53-induced degradation of hypoxia-inducible factor lalpha[J].Genes Dee,2000,14(1):34-44.

二级参考文献9

  • 1Semenza GL.Hypoxia inducible factor 1 : oxygen homeostasis and disease pathophysiology[J]. Trends Mol Med, 2001, 7(8):345-350
  • 2Semenza GL, Targeting HIF-1 for cancer therapy[J]. Nat Rev Cancer, 2003, 3(10):721-732
  • 3Zagzag D, Zhong H, Scalzitti JM, et al. Expression of hypoxia-inducible factor lalpha in brain tumors: association with angiogenesis, invasion, and progression[J]. Cancer, 2000, 88(11):2606-2618
  • 4Gong Y, Agani FH. Oligomycin inhibits HIF-1 expression in hypoxic tumor cells [J]. Am J Physiol Cell Physiol, 2005, 288 (5):1023 - 1029
  • 5Yeo EJ, Chun YS, Park JW. New anticancer strategies targeting HIF-1[J].Biochem Pharmacol, 2004, 68(6):1061-1069
  • 6Yatabe N, Kyo S, Maida Y, et al. HIF-1-mediated activation of telomerase in cervical cancer cells [J].Oncogene, 2004, 23 (20):3708-3715
  • 7Gwyther SJ. New imaging techniques in cancer management [J].Ann Oncd, 2005, 16(Suppl 2):ii63-ii70
  • 8Sunil S, Rainer W, Liliana D, et al. Gene expression profiling of malignant mesothelioma[J]. Clin Cancer Res, 2003, 9 (8):3080-3097
  • 9Comerford KM, Wallace TJ, Karhausen J, et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene[J]. Cancer Res, 2002, 62(12):3387-3394

共引文献4

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部